Continuous versus intermittent infusion of vancomycin in severe staphylococcal infections: Prospective multicenter randomized study

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 9, 2001, Pages 2460-2467

  Wysocki, M ^a   Delatour, F ^a   Faurisson, F ^a   Rauss, A ^a   Pean, Y ^a   Misset, B ^a   Thomas, F ^a   Timsit, J F ^a   Similowski, T ^a   Mentec, H ^a   Mier, L ^a   Dreyfuss, D ^a  

^a INSTITUT MUTUALISTE MONTSOURIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VANCOCYN; VANCOMYCIN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; COST EFFECTIVENESS ANALYSIS; DRUG BLOOD LEVEL; DRUG COST; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG INFUSION; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FEVER; FRANCE; HOSPITAL INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTICENTER STUDY; NEPHROTOXICITY; PHLEBITIS; PRIORITY JOURNAL; RANDOMIZATION; STAPHYLOCOCCUS INFECTION;

ADULT; AGED; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME; VANCOMYCIN;

EID: 17944367778     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.9.2460-2467.2001     Document Type: Article

References (28)

1. Ventricular staphylococcal infections. Treatment with vancomycin by continuous venous infusion
2. Continuous infusion of vancomycin during the neonatal period
3. Continuous infusion of vancomycin in post-neurosurgical staphylococcal meningitis in adults
4. Prediction of creatinine clearance from serum creatinine
5. Continuous administration of vancomycin in patients with severe burns
6. Vancomycin revisited
7. Penetration of vancomycin into human lung tissue
8. Diagnosis and management of methicillin resistant Staphylococcus aureus infection
9. Efficacies of different vancomycin dosing regimens against Staphylococcus aureus determined with a dynamic in vitro model
10. Mississippi mud in the 1990s. Risk and outcomes of vancomycin-associated toxicity in general oncology practice
11. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: Project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals
12. CDC definitions for nosocomial infections, 1988
13. Pharmacodynamics of vancomycin alone and in combination with gentamicin at various dosing intervals against methicillin-resistant Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model
14. Comparison of conventional dosing versus continuous-infusion vancomycin therapy for patients with suspected or documented gram-positive infections
15. Outcome assessment of minimizing vancomycin monitoring and dosing adjustments
16. Prognosis in acute organ system failure
17. Analysis of vancomycin entry into pulmonary lining fluid by bronchoalveolar lavage in critically ill patients
18. The clinical efficacy of continuous-infusion flucloxacillin in serious staphylococcal sepsis
19. A simplified acute physiology score for ICU patients
20. Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis
21. Pharmacokinetics of vancomycin
22. Nephrotoxicity of vancomycin, alone and with an aminoglycoside
23. Why monitor peak vancomycin concentrations?
24. Antibiogram committee of the French Society for Microbiology. 1996 Statement
25. Traitement d'infections à staphylocoques chez l'adulte par perfusion veineuse continue de vancomycine en monothérapic
26. Comparative studies of the bactericidal, morphological and post-antibiotic effects of arbekacin and vancomycin against methicillin-resistant Staphylococcus aureus
27. A closer look at vancomycin, teicoplanin and antimicrobial resistance
28. Antibiotics by continuous infusion: Saving money without sacrificing quality of care